Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/2022 → 30/09/2026 |
Collaborative partners
- King's College London (lead)
- UCB Pharma Limited
Funding
- UCB Pharma Ltd: £60,000.00
Integrating polygenic risk scores with clinical drug development
- Lewis, Cathryn (Primary Investigator)
- Coleman, Jonathan (Co-Investigator)
Project: Research